# Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

> **NCT06074315** · NA · UNKNOWN · sponsor: **Nail Genesis LLC** · enrollment: 338 (estimated)

## Conditions studied

- Distal Lateral Subungual Onychomycosis
- Onychomycosis

## Interventions

- **DEVICE:** Nail Genesis DLSO Product
- **DEVICE:** Nail Genesis DLSO Product (vehicle only)

## Key facts

- **NCT ID:** NCT06074315
- **Lead sponsor:** Nail Genesis LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 338 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06074315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06074315, "Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06074315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*